Search Within

Neil Howard Segal

Formats
  1. Meeting Abstract (110)
  2. Journal Article (95)
  3. Review (2)
  4. Book Section (1)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (210)
  2. Gastrointestinal Oncology Service (210)
  3. Solid Tumor Oncology Division (210)
  4. Center for Pancreatic Cancer Research (97)
  5. Surgery (80)
  6. Survivorship Research (78)

More Groups

People
  1. Leonard Saltz (81)
  2. Andrea Cercek Hanjis (68)
  3. Zsofia Stadler (67)
  4. Martin Weiser (61)
  5. Rona Yaeger (60)
  6. Jinru Shia (55)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (12)
  4. 2022 (14)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (78)
  2. Annals of Oncology (21)
  3. Clinical Cancer Research (9)
  4. Cancer Research (6)
  5. Journal for ImmunoTherapy of Cancer (6)
  6. Modern Pathology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Oxford University Press (26)
  3. American Association for Cancer Research (21)
  4. Elsevier Inc. (19)
  5. Nature Publishing Group (10)
  6. Biomed Central Ltd (6)

More Publishers

Results (210)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nonoperative management of mismatch repair-deficient tumors
    Journal Article

    Cercek, A.; Foote, M. B.; Rousseau, B.; Smith, J. J.; Shia, J.; Sinopoli, J.; Weiss, J.; Lumish, M.; Temple, L.; Patel, M.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Correlation between grade of clinical response to neoadjuvant therapy for rectal cancer and oncologic outcomes in the era of watch-and-wait
    Journal Article

    Rosen, R. Y.; Bercz, A. P.; Omer, D. M.; Verheij, F. S.; Williams, H.; Malekzadeh, P.; Kong, D. L.; Quezada-Diaz, F. F.; Wei, I. H.; Widmar, M.; more...
    Diseases of the Colon and Rectum (2025)

    Fulltext@MSK | Save
  • Co-formulated favezelimab plus pembrolizumab versus standard-of-care in previously treated, PD-L1-positive metastatic colorectal cancer: The phase 3, randomized KEYFORM-007 study
    Meeting Abstract

    Segal, N. H.; Passhak, M.; Köse, F.; Kubala, E.; Elez, E.; Kawakami, H.; Guren, M. G.; Jonker, D. J.; Xu, R. H.; Riera, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM)
    Meeting Abstract

    Fakih, M.; Segal, N. H.; Schlechter, B. L.; Andre, T.; Pietrantonio, F.; Johnson, B.; Vasilyev, A.; Krishnamurthi, S. S.; Siena, S.; Messersmith, W. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Outcomes of distal rectal cancer patients who did not qualify for watch-and-wait-comparison of intersphincteric resection versus abdominoperineal resection
    Meeting Abstract

    Feferman, Y.; Verheij, F. S.; Williams, H.; Omer, D. M.; Pappou, E. P.; Wei, I. H.; Widmar, M.; Nash, G. M.; Paty, P. B.; Smith, J. J.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes of distal rectal cancer patients who did not qualify for watch-and-wait: Comparison of intersphincteric resection versus abdominoperineal resection
    Journal Article

    Feferman, Y.; Verheij, F. S.; Williams, H.; Omer, D. M.; Pappou, E. P.; Wei, I. H.; Widmar, M.; Nash, G. M.; Paty, P. B.; Smith, J. J.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1/2 study of REGN7075 (EGFRA-CD28) combined with cemiplimab (anti-PD-1) In NSCLC: Trial in progress update
    Meeting Abstract

    Johnson, M. L.; Girda, E.; Sohal, D.; Lakhani, N. J.; Olszanski, A. J.; Fong, L.; Kinnaman, M.; Han, H.; Moesta, A.; Hao, Y.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
    Journal Article

    Bercz, A.; Park, B. K.; Pappou, E.; Nemirovsky, D.; Sarkar, R.; Yamner, M.; Omer, D.; Verheij, F. S.; Alvarez, J.; Atri, P.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti-PD-1) in patients with advanced solid tumors, including colorectal cancer: Trial in progress update
    Meeting Abstract

    Segal, N. H.; Girda, E.; Sohal, D.; Lakhani, N. J.; Olszanski, A. J.; Fong, L.; Han, H.; Casey, K. A.; Li, S.; Ganguly, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial
    Journal Article

    Williams, H.; Yuval, J. B.; Verheij, F. S.; Miranda, J.; Lin, S. T.; Omer, D. M.; Qin, L. X.; Gollub, M. J.; Kim, T. H.; Garcia-Aguilar, J.; more...
    British Journal of Surgery (2024)

    Fulltext@MSK | Save